STOK icon

Stoke Therapeutics

96 hedge funds and large institutions have $173M invested in Stoke Therapeutics in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 36 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
-4
Holders Change %
-4%
% of All Funds
1.53%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
17
Increased
25
Reduced
36
Closed
20
Calls
$283K
Puts
$18K
Net Calls
+$265K
Net Calls Change
-$2.59M
Name Holding Trade Value Shares
Change
Shares
Change %
SSA
101
Schonfeld Strategic Advisors
New York
-$669K -62,902 Closed
Connor, Clark & Lunn Investment Management (CC&L)
102
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$484K -45,575 Closed
Renaissance Technologies
103
Renaissance Technologies
New York
-$450K -42,300 Closed
TD Asset Management
104
TD Asset Management
Ontario, Canada
-$278K -26,186 Closed
Norges Bank
105
Norges Bank
Norway
-$263K -24,700 Closed
PP
106
PDT Partners
New York
-$251K -23,592 Closed
Belvedere Trading
107
Belvedere Trading
Illinois
-$168K -15,783 Closed
BFM
108
Boothbay Fund Management
New York
-$151K -14,180 Closed
Franklin Resources
109
Franklin Resources
California
-$134K -12,643 Closed
Russell Investments Group
110
Russell Investments Group
United Kingdom
-$14.7K -1,382 Closed
S
111
SignatureFD
Georgia
-$11K -1,031 Closed
LC
112
Lindbrook Capital
California
-$4.38K -412 Closed
EWA
113
EverSource Wealth Advisors
Alabama
-$1.35K -127 Closed
Osaic Holdings
114
Osaic Holdings
Arizona
-$1.06K -100 Closed
PA
115
Parallel Advisors
California
-$606 -57 Closed